CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity.
Saved in:
| Title: | CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity. |
|---|---|
| Authors: | Liu CC; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Yang WB; Research Center for Neuroscience, Taipei Medical University, Taipei, Taiwan.; Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Chien CH; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; School of Medicine, I-Shou University, Kaohsiung, Taiwan., Wu CL; Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng-Kung University, Tainan, Taiwan., Chuang JY; Research Center for Neuroscience, Taipei Medical University, Taipei, Taiwan.; International Master Program in Medical Neuroscience, Taipei Medical University, Taipei, Taiwan.; Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan., Chen PY; School of Medicine, Chang Gung University, Taoyuan, Taiwan.; Department of Neurosurgery, Keelung Chang Gung Memorial Hospital, Keelung, Taiwan., Chu JM; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Cheng SM; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Qiu LY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Chang YC; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.; TMU Research Center of Cancer Translational Medicine; Taipei Cancer Center; Taipei Medical University Hospital, College of Medicine, Taipei Medical University, Taipei, Taiwan., Hwang DY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Huang CY; Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lee JS; Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chang KY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. kwang2@nhri.edu.tw.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. kwang2@nhri.edu.tw.; Center of Cell Therapy, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. kwang2@nhri.edu.tw. |
| Source: | Cell death & disease [Cell Death Dis] 2024 Jun 19; Vol. 15 (6), pp. 434. Date of Electronic Publication: 2024 Jun 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-4889 |
|---|---|
| DOI: | 10.1038/s41419-024-06784-6 |
